New Enterprise Associates is a prominent venture capital firm focusing on investments in technology and healthcare startups. They help entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from the seed stage through the IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

New Enterprise Associates

Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of the human genome has given scientists new insights into the causes of human disease. These insights, combined with the past 20 years of developments in the biotechnology industry, are leading to rapid expansion of novel approaches toward the diagnosis, prevention, and treatment of life-threatening illnesses. These advances have led to an ever-increasing demand for capital to complete the development and commercialization of new therapeutics. Our goal is to support the leading global healthcare companies that are building on these technical and medical breakthroughs to commercialize new healthcare products.

Aisling Capital

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler.  The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in space.

Lightstone Ventures

Cochlear help people hear and be heard. The company empowers people to connect with others and live a full life. They help transform the way people understand and treat hearing loss. They innovate and bring to market a range of implantable hearing solutions that deliver a lifetime of hearing outcomes.

Cochlear

Medtronic provides healthcare technology solutions for complex and challenging conditions. They deliver treatments and therapies for the lungs, brain, dental, diabetes, ENT, heart, gastrointestinal, orthopedic, urinary, and women's health. The company's technologies and therapies treat 70 different medical conditions and include patient monitoring systems, robotic surgery, insulin pumps, cardiac devices, and more. Medtronic delivers innovative technologies that change people's lives through to its extensive knowledge, insatiable curiosity, and desire to assist everyone in need.

Medtronic

Vertex Ventures is a global network of operator-investors who manage portfolios in the U.S., China, Israel, India and Southeast Asia. The firm is a trusted partner to some of the world’s most innovative entrepreneurs, supporting them with unmatched operating experience and deep access to the capital, talent, partners and customers they need to build truly global businesses.

Vertex Ventures

Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health. Their portfolio includes companies at all stages of development, from early-stage companies testing transformative technologies to commercial-stage companies seeking additional growth. With a focus on areas with significant unmet need, Vertex seeks to build great companies that improve the health and quality of human life. They take an active role in our portfolio companies and work with exceptional entrepreneurs, industry partners and fellow venture investors to create value. Their global investment professionals bring deep scientific, medical and business knowledge to every investment they make.

Vertex Ventures HC

Founded in 2006, Windham is a New York City based venture capital firm focused on healthcare, with a particular emphasis on medical technology (devices and diagnostics) and digital health (the intersection of biology, genomics, and information technology).   Windham seeks to invest in and partner with companies that are commercializing game-changing technologies to serve unmet needs in order to improve the lives of large numbers of patients and yield robust returns for its investors.   For more information visit: www.windhamvp.com

Windham Venture Partners

SightLine Partners manages venture funds that invest in late stage medical technology companies .

SightLine Partners

CRG is a market pioneer and innovator in healthcare investing that focuses on intellectual property investments in FDA-approved biopharmaceutical assets through royalty bonds, structured debt, revenue interests, and traditional royalty monetizations. The company targets investments between $20 and $200 million and works directly with leading healthcare companies, research institutions, and inventors to provide customized financing structures to meet their unique needs. Its financings are an attractive alternative to costly equity financings and restrictive debt financings. CRG helps healthcare organizations fund pipeline development, make acquisitions, and expand into new markets—all with an adaptable source of capital. Capital Royalty strives to help biopharma companies access capital that has little to no dilution. While much of the capital that we invest allows our counterparties to fund innovative research and development products, our primary source of collateral is derived from commercialized products. As the only investment team with experience in structuring royalty bonds, structured debt, and traditional royalty monetizations, Capital Royalty is uniquely qualified to meet a broad range of financing needs for healthcare companies. CRG provides superior risk-adjusted returns to our investors by offering the most attractive financing alternatives to our business partners. Its investors include pension funds, insurance companies, family offices, university endowments, foundations, financial institutions, and other institutional investors.

The Richard King Mellon Foundation approved 190 grants totaling $104,578,500, and paid out commitments totaling $115,292,182.

Richard King Mellon Foundation

KCK is a family investment fund that invests in a diverse set of industries, including medical technologies. KCK interests in Life Sciences - Biopharm/ Biotech & MedTech, Energy, Science-rich companies and Industrial Technologies. KCK invest at all stages of a startup's from early stage to growth rounds and also invest in public companies. KCK is the private equity arm of a family office which seeks to partner with experienced management teams, focused on niche markets, deploying long-term flexible capital to generate high risk-adjusted returns.

ARCH Healthcare Fund is an investment firm based California.

ARCH Healthcare Fund

GDN Holdings, LLC operates as a healthcare management advisory company. The company was founded in 1998 and is based in Minnetonka, Minnesota.

GDN Holdings

Far East Capital is the family office of Far East Organization, one of the largest private real estate developers in Singapore.

Far East Capital

Relativity Healthcare Partners focuses on providing growth funding to emerging healthcare enterprises. They invest in seed-stage, early-stage, and late-stage firms.

Relativity Healthcare Partners

The Andrew W. Mellon Foundation endeavors to strengthen, promote, and, where necessary, defend the contributions of the humanities and the arts to human flourishing and to the well-being of diverse and democratic societies.

Andrew W. Mellon Foundation

Exor Ventures is the venture capital arm of Exor, one of Europe's largest diversified holding companies. Exor Ventures focuses on early and growth-stage investments in technology-driven companies across various sectors, including digital services, fintech, cybersecurity, and mobility. Exor Ventures leverages its strategic insights and global network to identify promising startups with disruptive potential and supports them through funding, mentorship, and access to its extensive resources.   EXOR Seeds offers a truly different type of partnership to the select group of entrepreneurs that it backs: - As a fifth-generation family-led business, we proved that we are builders not traders; - Our permanent capital allows us to take a long-term view and put the interest of the companies We invest in first; - Our global network, across industries and geographies, is a unique advantage to entrepreneurs

Exor Ventures

Sightline Healthcare Opportunity provides financial and funding assistance to various companies. It is managed by Sightline Partners to offer private equity investments.

Sightline Healthcare Opportunity

MS Pace LP

Baltisches Haus operates as a real estate management company.

Baltisches Haus

Earlens

Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens Contact Hearing Solution, which directly activates natural hearing, delivering the broadest bandwidth available today and superior sound quality. This revolutionary, non-surgical hearing solution uses a small lens to vibrate the eardrum, replicating the natural hearing process.  The Earlens Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the Earlens Contact Hearing Solution™ is the world’s first to deliver sound directly to the eardrum.

Earlens Corporation, now rebranded as Virsono Hearing Centers as of April 2024, is a provider of innovative hearing solutions and telehealth-enabled audiology services. Their flagship product, the Earlens Hearing System, utilizes a unique technology that involves placing a custom-fitted lens directly on the eardrum. This lens gently vibrates the eardrum across the full frequency range, transmitting high-fidelity audio signals from the ear tip.

Request Info - Learn More About Our Hearing Aids

Virsono Hearing Centers Emerges: Pioneering the Future of Hearing Innovation

Earlens Renames its Hearing Centers

A 10-Year Review of the Earlens System, Part 1: Speech Understanding and Broader Audibility

Providers

Earlens Hearing System Review: What Experts Say (2024)

Audiologist, Hearing Aids in Orange County

From counting steps to saving lives and beyond

Wearable Tech

EARLENS ANNOUNCES APPOINTMENT OF ROBERT GLAZER AS STRATEGIC ADVISOR

Earlens Corporation, now rebranded as Virsono Hearing Centers as of April 2024, is a provider of innovative hearing solutions and telehealth-enabled audiology services. Their flagship product, the Earlens Hearing System, utilizes a unique technology that involves placing a custom-fitted lens directly on the eardrum. This lens gently vibrates the eardrum across the full frequency range, transmitting high-fidelity audio signals from the ear tip.
The Earlens Hearing System offers several key advantages over traditional hearing aids. It provides a broader bandwidth, up to 10,000 Hz, allowing for enhanced audibility of high-frequency sounds crucial for speech understanding. Additionally, the direct vibration of the eardrum results in exceptional sound quality, closely resembling natural hearing.
Clinical research has demonstrated the superiority of the Earlens system in various aspects of auditory perception. Studies have shown significant improvements in speech recognition, consonant recognition, and word-final /s/ detection when compared to conventional hearing aids. Furthermore, the extended audible bandwidth has been proven to enhance speech understanding in complex, noisy environments.
The Earlens Hearing System is suitable for individuals aged 18 and above with mild to severe sensorineural hearing loss. It offers personalized settings through a user-friendly app, allowing wearers to fine-tune the device according to their preferences and unique hearing needs. In April 2024, Earlens Corporation announced the acquisition of its hearing centers by a new entity, Virsono Hearing Centers, as part of its commitment to broadening hearing care treatment and meeting evolving patient needs.

Biostrap is a company that provides scalable and customizable biosensor-based precision health monitoring solutions. Their innovative wearable devices, such as the Biostrap Kairos launched in July 2023, offer advanced autonomic nervous system analysis and quantification of the sympathetic and parasympathetic branches through wrist-worn devices. Kairos utilizes a high-sensitivity CMOS optical sensor to capture raw photoplethysmography (PPG) data, enabling accurate computation of biometrics like heart rate, heart rate variability (HRV), beat-to-beat intervals, respiratory rate, and sleep-related parameters.
Biostrap's key differentiator lies in its commitment to delivering clinically reliable nervous system analysis through detailed and transparent biometric measurements. The Spot Check feature provides real-time visualization of the underlying PPG signal, signal quality, and R-R intervals, granting untethered access to every data point captured. This configurability and data integrity attracted clients like the National Police Wellbeing Service (NPWS) in the UK for their sleep, fatigue, and recovery program.
Kairos underwent extensive testing by HRV experts and achieved impressive accuracy levels, comparable to ECG chest straps. The launch marked Biostrap's pivot from the consumer wearable market to offering configurable hardware and software solutions for enterprise and research purposes.

Biostrap

Caeden is a wearable technology company that develops smart bracelets focused on promoting mindfulness and reducing stress. Their flagship product, the Sona smart bracelet, combines fashion and technology by integrating an advanced heart rate sensor into a genuine leather bracelet design. Launched in May 2016, the Sona retailed for USD 200 and offered a unique "Resonance" program, consisting of various breathing exercises tailored for different moments throughout the user's day.
The Sona aimed to provide a reprieve from the fast-paced city life by enabling users to start their day with a moment of zen, find calm and focus before important meetings, and unwind after workouts through concentrated breathing exercises. Caeden's founders, Nora Levinson and David Watkins, believed that regular use of the Resonance program could help build the user's resistance to stress, addressing a significant health issue faced by many.
Differentiating itself from step-tracking devices like Fitbit and smartwatches acting as smartphone extensions, the Sona positioned itself as a luxury item powered by technology designed to improve the wearer's overall quality of life through mindfulness. With its discreet design concealing the technology, the Sona aimed to offer mindfulness without drawing attention to the wearer's use of a device for that purpose.

Caeden

MyKronoz is a Swiss company that specializes in producing innovative hybrid smartwatches. Their flagship product, the ZeTime, was first launched in 2017 after a successful crowdfunding campaign on Kickstarter. The ZeTime features a unique design that combines traditional mechanical watch hands with a full-color touchscreen display, allowing it to function as both an analog watch and a smartwatch.
The watch offers activity tracking capabilities, including monitoring steps, calories burned, and sleep patterns using built-in sensors such as an accelerometer and optical heart rate monitor. It also provides smartwatch functionalities like displaying notifications, controlling music playback, and viewing incoming calls. The ZeTime's mechanical hands intelligently adjust their position to avoid obstructing the touchscreen display when interacting with the device.
One of the key advantages of the ZeTime is its impressive battery life. In watch mode, the battery can last up to 30 days on a single charge, while the smartwatch mode offers around 3-4 days of usage. The device also allows users to customize watch faces, either by selecting from pre-set options or creating their own designs using templates or personal photos.
The ZeTime received praise for its innovative concept and strong battery life. Some reviews, however, criticized its half-baked operating system, unresponsive touchscreen, and inconsistent activity tracking. Despite these drawbacks, MyKronoz's hybrid smartwatches garnered global recognition for their unique approach to wearable technology.

MyKronoz

Ringly is a company that produces fashionable smart jewelry, primarily rings and bracelets, aimed at the female market. Their devices are designed to discreetly notify wearers of incoming calls, messages, and app notifications through vibrations and LED lights. The rings are made from materials like 14k gold, sterling silver, and semi-precious gemstones like onyx, labradorite, and moonstone.
Ringly's core product is a smart ring that connects to the user's smartphone via Bluetooth. Through the Ringly app, users can customize which notifications trigger the ring's vibrations and colored LED lights. The app supports over 100 apps like calls, texts, emails, calendar alerts, and social media platforms. The rings are water-resistant and have a battery life of 2-3 days.
While technologically simple, Ringly's rings prioritize a fashionable and discreet design over advanced features. The idea is to provide a stylish alternative to smartwatches that seamlessly blends into the user's wardrobe and lifestyle without being obtrusive. Ringly has focused on creating fashionable jewelry pieces that also offer practical notification capabilities.

Ringly

Healbe Corporation is a technology company that develops wearable devices and associated software for health and wellness monitoring. The company's flagship product is the Healbe GoBe, a smart band that utilizes proprietary FLOW Technology to automatically track various body parameters. The GoBe device employs a combination of sensors, including an accelerometer, piezo pressure sensor, and impedance sensor, along with advanced algorithms to provide insights into users' overall health.
The GoBe smart band is designed to automatically measure calorie intake through the skin, eliminating the need for manual food logging. It also tracks calories burned, hydration levels, stress levels, sleep quality, heart rate, blood pressure, and physical activity. In November 2015, Healbe introduced automatic hydration level monitoring to the GoBe device, making it the first wearable to offer this feature without requiring manual input of fluid consumption.
Healbe's technology adapts to individual body characteristics, providing personalized insights and recommendations. The device monitors hydration levels continuously and alerts users when they need to drink more water. It also tracks emotional stress and helps users correlate it with their body's physical responses. The GoBe smart band measures energy expenditure throughout the day, including basal metabolism, regardless of physical activity levels.
The company's latest model, the GoBe3, incorporates additional features such as EDA-based Neuroactivity tracking and physiological stress estimation. It also offers improved sleep tracking capabilities, including detailed analysis of sleep phases and smart alarm functions designed to wake users during optimal sleep stages.
Healbe has developed a companion mobile application that synchronizes with the GoBe device in real-time, allowing users to view and analyze their data. The app provides detailed information on various health parameters and offers integration with Google Fit for a more comprehensive health data ecosystem.

Healbe

Wearable devices in form factors, such as wristwear and rings, designed to monitor and track various aspects of a person's physical activity, health, and wellness

Wearable entertainment devices designed primarily for entertainment and leisure purposes. These come in the form of hearables, wearable cameras, personalized smart devices, etc.

Apparel that incorporate electronic components, sensors, and connectivity features to provide functionalities beyond traditional clothing and accessories

Specialized wearable devices designed for use in industrial and work settings. These include safety wearables that come in the form of head-mounted devices, smart gloves, exoskeletons, etc.

Wearable devices, which are designed to monitor, collect, and transmit various health-related data, and wearable assistive devices. These come in the form of cardiac monitoring devices, glucose monitors, wearable pulse oximeters, hearing impairment aids, visual aids, etc.

Enhances the user experience by enabling language translation, contextual awareness, and personalized recommendations, making wearables more versatile and user-centric

Leveraging technology to collect data about the user's activities, preferences, and health metrics before using this information to provide personalized experiences

Industrial wearables contribute to increased efficiency, safety, and productivity in industrial settings by providing real-time data and connectivity solutions for workers and equipment

Empowers wearable devices to continuously improve and adapt to user preferences, offering personalized insights and recommendations based on user data

Enhances the functionality of wearables and allows users to access and interact with data through various devices and services in the broader IoT ecosystem

Earlens

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless